The “neuro” of neuroblastoma: <scp>N</scp>euroblastoma as a neurodevelopmental disorder

Annals of Neurology - Tập 80 Số 1 - Trang 13-23 - 2016
Nancy Ratner1, Garrett M. Brodeur2, Russell C. Dale3, Nina F. Schor4
1Department of Pediatrics Cincinnati Children's Hospital and University of Cincinnati Cincinnati OH
2Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
3Clinical School, the Children's Hospital at Westmead University of Sydney Sydney New South Wales Australia
4Department of Pediatrics, University of Rochester Medical Center, Rochester, NY

Tóm tắt

Neuroblastoma is a childhood cancer derived from cells of neural crest origin. The hallmarks of its enigmatic character include its propensity for spontaneous regression under some circumstances and its association with paraneoplastic opsoclonus, myoclonus, and ataxia. The neurodevelopmental underpinnings of its origins may provide important clues for development of novel therapeutic and preventive agents for this frequently fatal malignancy and for the associated paraneoplastic syndromes. Ann Neurol 2016;80:13–23

Từ khóa


Tài liệu tham khảo

10.1177/0883073813483173

10.1126/science.1222369

10.1101/cshperspect.a020487

10.1101/cshperspect.a014415

Spengler BA, 1997, Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells, Oncol Res, 9, 467

10.1038/sj.onc.1210965

10.18632/oncotarget.2611

10.1016/j.stem.2015.02.017

10.1016/j.crvi.2007.04.004

10.1242/dmm.018630

10.1016/j.scr.2015.08.008

10.1593/neo.04310

10.18632/oncotarget.5104

10.1093/emboj/16.11.2985

10.1371/journal.pone.0133897

10.1016/j.cell.2010.06.004

10.1038/ng.3333

10.1038/nrclinonc.2014.168

10.3109/02841869009090048

Papac RJ, 1998, Spontaneous regression of cancer: possible mechanisms, In Vivo, 12, 571

10.1007/s00268-012-1837-0

10.1200/JCO.1996.14.2.373

10.1056/NEJMoa012277

10.1056/NEJMoa012387

10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I

10.1158/1078-0432.CCR-08-1815

10.1158/1078-0432.CCR-08-0651

Nakagawara A, 1992, Inverse relationship between trk expression and N‐myc amplification in human neuroblastomas, Cancer Res, 52, 1364

10.1056/NEJM199303253281205

10.1128/MCB.14.1.759

Jaboin J, 2002, Brain‐derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy‐induced apoptosis via phosphatidylinositol 3′‐kinase pathway, Cancer Res, 62, 6756

Matsumoto K, 1995, Expression of brain‐derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells, Cancer Res, 55, 1798

10.1016/S0959-8049(97)00280-3

10.1016/j.ccr.2004.09.011

10.1016/0304-3835(93)90182-9

10.1212/WNL.62.9.1526

10.1002/mpo.1138

10.1038/sj.onc.1208594

10.1016/0022-3468(90)90375-J

10.1126/science.7605428

10.1038/nm0395-249

10.4161/epi.6.8.16516

10.1038/ng.2529

10.1016/j.semcancer.2004.06.005

10.1517/17460441.2015.974544

10.1016/j.braindev.2014.10.010

10.1542/peds.2010-3114

10.1136/adc.2010.204792

10.1002/mpo.1139

10.1111/dmcn.12594

10.1016/j.jneuroim.2013.11.004

10.1002/ana.20539

10.1016/j.jneuroim.2015.07.007

10.1016/S0887-8994(02)00457-5

10.1016/j.pediatrneurol.2011.02.012

10.1002/mds.20125

10.1186/1742-2094-10-10

10.1189/jlb.0213106

10.1007/s10875-013-9867-4

10.1177/08830738040190120201

10.1111/cei.12065

10.1177/0883073811428816

10.1177/0883073814549581

10.1212/WNL.0000000000000570

10.1016/j.febslet.2013.11.030

10.1080/2162402X.2015.1016704

10.1002/pbc.25197

Chelmicka‐Schorr E, 1978, Modulatory effect of the sympathetic nervous system on neuroblastoma tumor growth, Cancer Res, 38, 1374

10.1172/JCI115655

Fink DW, 1987, Effects of chemical sympathectomy in neonatal and adult mice on C‐1300 neuroblastoma tumor growth and catecholamine content, Cancer Res, 47, 5620

Purpura P, 1996, Adjunctive treatment of murine neuroblastoma with 6‐hydroxydopamine and Tempol, Cancer Res, 56, 2336

10.5603/NMR.2015.0024

Bleeker G, 2015, 123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma, Cochrane Database Syst Rev, 9, CD009263

10.1016/j.ejca.2015.07.023

Yan C, 2002, TrkA as a life and death receptor: receptor dose as a mediator of function, Cancer Res, 62, 4867

10.1124/mol.61.4.710

10.1172/JCI65988

Dole MG, 1995, Bcl‐xL is expressed in neuroblastoma cells and modulates chemotherapy‐induced apoptosis, Cancer Res, 55, 2576

10.18632/oncotarget.3901

10.1046/j.1471-4159.1996.67031259.x

Cortazzo M, 1996, Potentiation of enediyne‐induced apoptosis and differentiation by Bcl‐2, Cancer Res, 56, 1199

10.1023/A:1006171406740

10.1124/mol.61.1.142

10.1038/sj.onc.1206844

10.1007/s00280-005-0054-z

10.1007/s00280-008-0725-7

Peinemann F, 2015, Retinoic acid post consolidation therapy for high‐risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation, Cochrane Database Syst Rev, 1, CD010685

10.1016/j.yexcr.2012.12.027

10.1002/cncr.29706

Li X, 2014, Methylase meets phosphatase: roles of PRMT and EYA1 in neuroblastoma, AACR Proc

10.1177/0883073808324217

10.1002/pbc.23187

10.1158/2159-8290.CD-14-0892

Thông tin
Thông tin xuất bản

Annals of Neurology

Tập 80 Số 1

13-23

Thông tin tác giả